FDA Approves Coartem Tablets to Treat Malaria The U.S. Food
FDA Approves Coartem Tablets to Treat Malaria
The U.S. Food and Drug Administration has approved Coartem tablets (artemether and lumefantrine) for the treatment of acute, uncomplicated malaria infections in adults and children weighing at least five kilograms (approximately 11 pounds).